Skip to content

Total debt at other companies

Tango Therapeutics logo
Tango TherapeuticsTNGX
$32.79M-11.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$113M+88.3%
Erasca, Inc. logo
Erasca, Inc.ERAS
$45.95M-9.6%
Immunome logo
ImmunomeIMNM
$3.69M-22.6%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $28.6M.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s total debt?
IDEAYA Biosciences, Inc. (IDYA) reported total debt of $28.6M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s total debt changed year-over-year?
IDEAYA Biosciences, Inc.'s total debt increased by 10.1% year-over-year, from $25.97M to $28.6M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s total debt?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s total debt has grown at a 32.9% compound annual growth rate (CAGR), from $6.72M to $27.91M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.